X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15715) 15715
Newspaper Article (2528) 2528
Newsletter (1336) 1336
Magazine Article (244) 244
Book Chapter (94) 94
Government Document (39) 39
Web Resource (30) 30
Trade Publication Article (24) 24
Book / eBook (23) 23
Transcript (22) 22
Dissertation (13) 13
Reference (11) 11
Report (7) 7
Book Review (6) 6
Conference Proceeding (5) 5
Paper (5) 5
Streaming Video (5) 5
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12047) 12047
influenza (11455) 11455
female (4781) 4781
influenza, human - drug therapy (4452) 4452
male (4337) 4337
viruses (3639) 3639
animals (3511) 3511
infectious diseases (3285) 3285
adult (3235) 3235
vaccines (3075) 3075
health aspects (3065) 3065
antiviral agents - therapeutic use (2993) 2993
infections (2859) 2859
middle aged (2705) 2705
immunology (2545) 2545
research (2336) 2336
influenza, human - prevention & control (2275) 2275
pandemics (2251) 2251
influenza vaccines (2213) 2213
vaccination (2209) 2209
drug therapy (2139) 2139
aged (2129) 2129
influenza, human - epidemiology (2080) 2080
influenza, human - virology (2054) 2054
child (1987) 1987
adolescent (1958) 1958
antiviral agents (1903) 1903
infection (1829) 1829
virology (1818) 1818
influenza viruses (1610) 1610
mortality (1609) 1609
microbiology (1569) 1569
mice (1548) 1548
antiviral agents - pharmacology (1547) 1547
medicine (1531) 1531
immunization (1503) 1503
child, preschool (1496) 1496
medical research (1435) 1435
oseltamivir (1428) 1428
epidemics (1419) 1419
analysis (1400) 1400
prevention (1375) 1375
public health (1371) 1371
pharmacology & pharmacy (1362) 1362
virus diseases (1321) 1321
research article (1296) 1296
children (1291) 1291
risk factors (1289) 1289
infant (1247) 1247
proteins (1228) 1228
pneumonia (1213) 1213
care and treatment (1195) 1195
avian influenza (1190) 1190
viral infections (1190) 1190
young adult (1184) 1184
influenza, human - complications (1160) 1160
treatment outcome (1132) 1132
medicine, general & internal (1129) 1129
multidisciplinary sciences (1088) 1088
studies (1081) 1081
oseltamivir - therapeutic use (1046) 1046
clinical trials (1038) 1038
patients (1013) 1013
disease (985) 985
virus (985) 985
influenza, human - diagnosis (967) 967
pediatrics (953) 953
epidemiology (942) 942
influenza vaccines - administration & dosage (929) 929
influenza vaccines - immunology (912) 912
medicine, experimental (908) 908
influenza a virus, h1n1 subtype (903) 903
science (887) 887
drug resistance (873) 873
drugs (861) 861
influenza a virus (857) 857
neuraminidase - antagonists & inhibitors (853) 853
medicine, research & experimental (850) 850
swine influenza (847) 847
antigens (833) 833
influenza, human - immunology (820) 820
aged, 80 and over (762) 762
abridged index medicus (746) 746
diagnosis (744) 744
influenza a virus, h1n1 subtype - drug effects (738) 738
immune system (736) 736
immune response (733) 733
safety (732) 732
biology (727) 727
adults (723) 723
pharmaceutical industry (709) 709
antiviral agents - administration & dosage (695) 695
laboratories (695) 695
efficacy (688) 688
mutation (684) 684
usage (676) 676
coronaviruses (674) 674
inflammation (672) 672
hospitals (664) 664
zanamivir (661) 661
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (13) 13
Gerstein Science - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
New College (Ivey) - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19285) 19285
German (248) 248
Russian (245) 245
Japanese (159) 159
French (120) 120
Spanish (87) 87
Chinese (70) 70
Italian (39) 39
Portuguese (28) 28
Dutch (26) 26
Polish (26) 26
Danish (16) 16
Norwegian (12) 12
Swedish (11) 11
Hungarian (9) 9
Czech (6) 6
Croatian (5) 5
Finnish (5) 5
Korean (5) 5
Turkish (5) 5
Ukrainian (4) 4
Romanian (3) 3
Serbian (3) 3
Hebrew (2) 2
Bulgarian (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current medicinal chemistry, ISSN 0929-8673, 2018, Volume 25, Issue 7, pp. 814 - 838
Background: Autophagy is a cellular pathway with the ability to maintain cell homeostasis through the elimination of damaged or useless cellular components, and its deregulation may initiate or aggravate different human diseases... 
Flavonoids | autophagy | infectious diseases | hepatic diseases | cancer | cardiovascular diseases | neurodegenerative disorders | diabetes | HEPATOCELLULAR-CARCINOMA CELLS | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | APIGENIN-INDUCED APOPTOSIS | FATTY LIVER-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BREAST-CANCER CELLS | ROTENONE-INDUCED NEUROTOXICITY | REACTIVE OXYGEN | HELICOBACTER-PYLORI INFECTION | A VIRUS-INFECTION | PHARMACOLOGY & PHARMACY | CELL-DEATH INDUCTION | Diabetes Mellitus - pathology | Influenza, Human - pathology | Cardiovascular Diseases - drug therapy | Humans | Liver Diseases - pathology | Stomach Ulcer - pathology | Osteoporosis - drug therapy | Cardiovascular Diseases - pathology | Neurodegenerative Diseases - drug therapy | Leishmaniasis - pathology | Autophagy - drug effects | Flavonoids - pharmacology | Influenza, Human - drug therapy | Neurodegenerative Diseases - pathology | Diabetes Mellitus - drug therapy | Stomach Ulcer - drug therapy | Leishmaniasis - drug therapy | Asthma - drug therapy | Neoplasms - drug therapy | Osteoporosis - pathology | Cell Proliferation - drug effects | Liver Diseases - drug therapy | Neoplasms - pathology | Asthma - pathology | Flavonoids - chemistry | Deregulation | Identification methods | Homeostasis | Autophagy | Neuromodulation | Modulators | Metabolites | Heart diseases | Vector-borne diseases | Liver diseases | Cell survival | Neurodegenerative diseases | Invasiveness | Medical treatment | Leishmaniasis | Survival | Diseases | Side effects | Cell death | Ulcers | Influenza | Documents | In vivo methods and tests | Diabetes | Cardiovascular diseases | Phagocytosis | Cancer
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific antiviral therapy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | HERPES-SIMPLEX-VIRUS | TENOFOVIR DISOPROXIL FUMARATE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | POSITIVE CHRONIC HEPATITIS | CHRONIC HEPATITIS-B | ALPHA-2A PLUS RIBAVIRIN | CONGO HEMORRHAGIC-FEVER | ACUTE INTERSTITIAL NEPHRITIS | RECURRENT GENITAL HERPES | HIV-INFECTED PATIENTS | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Valacyclovir | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Valganciclovir | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Telbivudine | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Symposium on Antimicrobial Therapy
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 11, pp. 1136 - 1149
... tuberculosis , and multiazole-resistant fungi has focused attention on investments into development of new drugs and treatment regimens... 
Infectious Disease | INFECTIOUS DISEASES | INFLUENZA-A | ASPERGILLUS-FUMIGATUS | IN-VITRO | VIRUS-INFECTION | A DOUBLE-BLIND | OPEN-LABEL | CRITICALLY-ILL PATIENTS | T-CELLS | SYNDROME CORONAVIRUS | H1N1 VIRUS | Mycoses - epidemiology | Virus Diseases - epidemiology | Biological Therapy - methods | Biological Therapy - trends | Humans | Drug Resistance, Viral | Drug Resistance, Bacterial | Mycoses - microbiology | Virus Diseases - virology | Antifungal Agents - therapeutic use | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Virus Diseases - drug therapy | Respiratory Tract Infections - virology | Drug Resistance, Fungal | Bacterial Infections - microbiology | Drug Therapy - trends | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Drug Discovery - trends | Respiratory Tract Infections - drug therapy | Treatment Outcome | Drug Therapy - methods | Bacterial Infections - epidemiology | Mycoses - drug therapy | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Antiviral agents | Hospitals | Influenza | Mycoses | Development and progression | Bacteria | Cross infection | Nosocomial infections | Drug therapy | Cells | Drug resistance in microorganisms | Severe acute respiratory syndrome | Respiratory agents | Pandemics | Mortality | Respiratory diseases | Viral infections
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2014, Volume 59, Issue suppl_5, pp. S344 - S351
Despite preventive strategies and increased awareness, a high incidence of respiratory viral infections still occur in patients with hematologic malignancies... 
Human respiratory syncytial virus | Paramyxoviridae infections | Antivirals | Respiratory syncytial viruses | Viruses | Orthomyxoviridae | Infections | Viral infections | Cell transplantation | Hematopoietic stem cell transplantation | Antiviral therapy | Infection prevention | RSV | Immunocompromised host | Cancer | 2009 H1N1 INFLUENZA | INFECTIOUS DISEASES | SYNCYTIAL VIRUS-INFECTION | TRACT DISEASE | INTRAVENOUS ZANAMIVIR | AEROSOLIZED RIBAVIRIN | MICROBIOLOGY | PARAINFLUENZA VIRUS | RESISTANT INFLUENZA-VIRUS | IMMUNOLOGY | infection prevention | IN-VITRO | SIALIDASE FUSION PROTEIN | cancer | ACTING NEURAMINIDASE INHIBITOR | immunocompromised host | antiviral therapy | Paramyxoviridae Infections - etiology | Antiviral Agents - therapeutic use | Humans | Pneumonia, Viral - drug therapy | Recombinant Fusion Proteins - therapeutic use | Ribavirin - therapeutic use | Pneumonia, Viral - etiology | Hematopoietic Stem Cell Transplantation | Respiratory Tract Infections - drug therapy | Influenza, Human - etiology | Virus Diseases - etiology | Virus Diseases - drug therapy | Respiratory Syncytial Virus Infections - etiology | Respiratory Syncytial Virus Infections - drug therapy | Influenza, Human - virology | Respiratory Tract Infections - etiology | Hematologic Neoplasms - complications | Influenza, Human - drug therapy | Paramyxoviridae Infections - drug therapy | Respiratory Tract Infections - virology | The Third Infections in Cancer Symposium
Journal Article
FEMS microbiology reviews, ISSN 1574-6976, 2017, Volume 41, Issue 3, pp. 323 - 342
Journal Article
Antiviral research, ISSN 0166-3542, 2008, Volume 78, Issue 1, pp. 91 - 102
The currently circulating H3N2 and H1N1 subtypes of influenza A virus cause a transient, febrile upper respiratory illness in most adults and children... 
Avian influenza | Oseltamivir | Antiviral therapy | Adamantane | Influenza virus | Influenza | Neuraminidase | Peramivir | H5N1 influenza virus | Zanamivir | influenza | avian influenza | HUMAN INFECTION | CYTOKINE RESPONSES | A H5N1 VIRUS | LOWER RESPIRATORY-TRACT | RANDOMIZED CONTROLLED-TRIAL | HONG-KONG | HUMAN AIRWAY | adamantane | NEURAMINIDASE INHIBITOR | OSELTAMIVIR RESISTANCE | VIROLOGY | neuraminidase | influenza virus | PHARMACOLOGY & PHARMACY | peramivir | zanamivir | oseltamivir | IN-VIVO ACTIVITIES | antiviral therapy | Severity of Illness Index | Influenza A Virus, H3N2 Subtype - drug effects | Antiviral Agents - therapeutic use | Poultry | Humans | Influenza A Virus, H3N2 Subtype - pathogenicity | Birds | Influenza A Virus, H1N1 Subtype - pathogenicity | Influenza A Virus, H5N1 Subtype - drug effects | Poultry Diseases - virology | Influenza A Virus, H1N1 Subtype - drug effects | Poultry Diseases - drug therapy | Animals | Antiviral Agents - classification | Influenza in Birds - virology | Influenza A Virus, H5N1 Subtype - pathogenicity | Influenza in Birds - drug therapy | Influenza, Human - virology | Influenza, Human - drug therapy | Seasons | Influenza, Human - physiopathology | Virus diseases | Acute respiratory distress syndrome | Avian influenza viruses | Monoclonal antibodies | Drug resistance | Health aspects
Journal Article